Saudi - Delayed Quote SAR

Al Hammadi Holding Company (4007.SR)

39.85
-0.05
(-0.13%)
As of 10:03:06 AM GMT+3. Market Open.
Currency in SAR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,153,880.93
1,153,880.93
1,176,763.62
1,122,397.03
951,887.50
Cost of Revenue
771,426.53
771,426.53
743,619.19
702,725.85
587,840.13
Gross Profit
382,454.40
382,454.40
433,144.42
419,671.17
364,047.37
Operating Expense
92,972.24
92,972.24
107,813.03
139,449.45
226,362.32
Operating Income
289,482.16
289,482.16
325,331.39
280,221.73
137,685.05
Net Non Operating Interest Income Expense
-17,679.36
-17,679.36
-25,804.31
-21,709.42
-15,717.12
Pretax Income
354,679.79
354,679.79
320,955.29
274,150.97
117,560.46
Tax Provision
15,878.97
15,878.97
17,624.41
16,814.80
18,692.34
Net Income Common Stockholders
338,800.81
338,800.81
303,330.87
257,336.17
90,087.84
Diluted NI Available to Com Stockholders
338,800.81
338,800.81
303,330.87
257,336.17
90,087.84
Basic EPS
2.12
--
1.90
1.61
0.56
Diluted EPS
2.12
--
1.90
1.61
0.56
Basic Average Shares
160,000
--
160,000
160,000
160,000
Diluted Average Shares
160,000
--
160,000
160,000
160,000
Total Operating Income as Reported
365,634.92
365,634.92
342,574.86
291,784.96
131,229.21
Rent Expense Supplemental
546.74
546.74
452.28
2,934.93
74.50
Total Expenses
864,398.77
864,398.77
851,432.23
842,175.30
814,202.44
Net Income from Continuing & Discontinued Operation
338,800.81
338,800.81
303,330.87
257,336.17
90,087.84
Normalized Income
285,670.21
285,670.21
301,525.57
257,336.17
116,680.31
Interest Income
6,137.55
6,137.55
0
--
--
Interest Expense
23,816.91
23,816.91
25,804.31
21,709.42
15,717.12
Net Interest Income
-17,679.36
-17,679.36
-25,804.31
-21,709.42
-15,717.12
EBIT
378,496.69
378,496.69
346,759.60
295,860.38
133,277.58
EBITDA
475,491.84
475,491.84
446,860.07
396,273.89
242,707.80
Reconciled Cost of Revenue
771,426.53
771,426.53
743,619.19
702,725.85
587,840.13
Reconciled Depreciation
96,995.15
96,995.15
100,100.47
100,413.51
109,430.22
Net Income from Continuing Operation Net Minority Interest
338,800.81
338,800.81
303,330.87
257,336.17
98,868.13
Total Unusual Items Excluding Goodwill
55,620.73
55,620.73
1,910.20
0
-9,658.99
Total Unusual Items
55,620.73
55,620.73
1,910.20
0
30
Normalized EBITDA
419,871.11
419,871.11
444,949.87
396,273.89
242,677.81
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
2,490.13
2,490.13
104.89
0
-1,535.80
12/31/2021 - 7/15/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4002.SR Mouwasat Medical Services Company
77.30
-0.39%
 
4005.SR National Medical Care Company
164.00
+0.99%
 
4004.SR Dallah Healthcare Company
118.60
0.00%
 
4009.SR Middle East Healthcare Company
63.80
-0.31%
 
4013.SR Dr. Sulaiman Al Habib Medical Services Group Company
269.20
-0.30%
 
4018.SR Almoosa Health Company
163.80
-0.12%
 
4017.SR Dr. Soliman Abdel Kader Fakeeh
46.30
-0.11%
 
SGRY Surgery Partners, Inc.
22.77
-0.70%
 
PACS PACS Group, Inc.
10.93
-0.18%
 
FMS Fresenius Medical Care AG
27.85
-0.54%